Nimodipine

FDA Approved: * April 17, 2007
Pharm Company: * SUN PHARM INDS INC
Category: Blood Pressure

Nimodipine, sold under the brand name Nimotop among others, is calcium channel blocker used in preventing vasospasm secondary to subarachnoid hemorrhage (a form of cerebral hemorrhage). It was originally developed within the calcium channel blocker class as it was used for the treatment of high blood pressure, but is not used for this indication. It was patented in 1971[2] and approved for medical use in the US in 1988.[3] It was approved for medical use in G... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nimodipine b;980
Nimodipine 30 mg Oral Capsule
NDC: 0555-0980
Labeler:
Barr Laboratories Inc.
Nimodipine H108
Nimodipine 30 mg Oral Capsule
NDC: 23155-108
Labeler:
Heritage
Nimodipine H108
Nimodipine 30 mg Oral Capsule, Liquid Filled
NDC: 55154-4184
Labeler:
Cardinal Health
Nimodipine H108
Nimodipine 30 mg Oral Capsule
NDC: 60429-146
Labeler:
Golden State Medical Supply, Inc.
Nimodipine 30 mg Oral Capsule, Liquid Filled
NDC: 0904-6566
Labeler:
Major Pharmaceuticals
Nimodipine 30 mg Oral Capsule, Liquid Filled
NDC: 23155-512
Labeler:
Heritage Pharmaceuticals Inc.
Nymalize 60 mg/20ml Oral Solution
NDC: 24338-200
Labeler:
Arbor Pharmaceuticals
Nimodipine 60 mg/20ml Oral Solution
NDC: 31722-039
Labeler:
Camber Pharmaceuticals, Inc.
Nimodipine 30 mg Oral Capsule
NDC: 55154-4560
Labeler:
Cardinal Health
Nimodipine 30 mg Oral Capsule
NDC: 57664-135
Labeler:
Caraco Pharmaceutical Laboratories, Ltd.

Related Brands

Drugs with the same active ingredients